The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Case Studies
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).
Case Studies
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Advisory
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
Advisory
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…